Atlas Trials

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

Clinical trial NCT02537925 · UNKNOWN

Trial details

NCT number
NCT02537925
Sponsor
Changjie Huang
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2014-01-01
Primary completion
2016-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.